Publications for Qihan Dong
Publications for Qihan Dong
2016
Xi, Z., Yao, M., Li, Y., Holst, J., Liu, T., Cai, S.,
Lao, Y., Tan, H., Xu, H., Dong, Q. (2016).
Guttiferone K impedes cell cycle re-entry of
quiescent prostate cancer cells via stabilization of
FBXW7 and subsequent c-MYC degradation.
Cell Death and Disease, 7(6), 1-13. <a
href="http://dx.doi.org/10.1038/cddis.2016.123"
>[More Information]</a>
Meng, X., Xu, H., Yao, M., Dong, Q., Zhang, X.
(2016). Implication of unfolded protein response
and autophagy in the treatment of BRAF
inhibitor resistant melanoma. Anti-Cancer
Agents in Medicinal Chemistry, 16(3), 291-298.
2015
Hua, S., Vignarajan, S., Yao, M., Xie, C., Sved,
P., Dong, Q. (2015). AKT and cytosolic
phospholipase A2α form a positive loop in
prostate cancer cells. Current Cancer Drug
Targets, 15(9), 781-791.
Choi, J., Desai, R., Zheng, Y., Yao, M., Dong,
Q., Watson, G., Handelsman, D., Simanainen, U.
(2015). Androgen actions via androgen receptor
promote PTEN inactivation induced uterine
cancer. Endocrine-Related Cancer, 22(5),
687-701. <a
href="http://dx.doi.org/10.1530/ERC-15-0203">[
More Information]</a>
Meng, X., Yao, M., Zhang, X., Xu, H., Dong, Q.
(2015). ER stress-induced autophagy in
melanoma. Clinical and Experimental
Pharmacology and Physiology, 42(8), 811-816.
<a
href="http://dx.doi.org/10.1111/1440-1681.1243
6">[More Information]</a>
Hnit, S., Xie, C., Yao, M., Holst, J., Bensoussan,
A., de Souza, P., Li, Z., Dong, Q. (2015).
p27(Kip1) signaling: Transcriptional and
post-translational regulation. The International
Journal of Biochemistry and Cell Biology, 68,
9-14. <a
href="http://dx.doi.org/10.1016/j.biocel.2015.08.
005">[More Information]</a>
Yao, M., Xie, C., Kiang, M., Teng, Y., Harman,
D., Tiffen, J., Wang, K., Sved, P., Bao, B.,
Witting, P., Holst, J., Dong, Q. (2015). Targeting
of cytosolic phospholipase A2a impedes cell
cycle re-entry of quiescent prostate cancer cells.
Oncotarget, 6(33), 34458-34474. <a
href="http://dx.doi.org/10.18632/oncotarget.527
7">[More Information]</a>
Gamsjaeger, R., Kariawasam, R., Gimenez, A.,
Touma, C., McIlwain, E., Bernardo, R.,
Shepherd, N., Ataide, S., Dong, Q., Richard, D.,
Cubeddu, L., et al (2015). The structural basis of
DNA binding by the single-stranded
DNA-binding protein from Sulfolobus
solfataricus. The Biochemical Journal, 465(2),
337-346. <a
href="http://dx.doi.org/10.1042/BJ20141140">[
More Information]</a>
2014
Hua, S., Xie, C., Yao, M., Dong, Q. (2014).
Effect of Arachidonic Acid and its Producing
Enzyme Phospholipase A2 alpha on Key
Oncogenic Pathways in Prostate Cancer. In
Jason M. OKeefe (Eds.), Arachidonic Acid:
Sources, Biosynthesis and Health Effects, (pp.
135-164). New York: Nova Science Publishers,
Inc.
Vignarajan, S., Xie, C., Yao, M., Sun, Y.,
Simanainen, U., Sved, P., Liu, T., Dong, Q.
(2014). Loss of PTEN stabilizes the lipid
modifying enzyme cytosolic phospholipase A₂α
via AKT in prostate cancer cells. Oncotarget,
5(15), 6289-6299.
Xie, C., Yao, M., Dong, Q. (2014). Proliferating
cell unclear antigen-associated factor (PAF15):
A novel oncogene. The International Journal of
Biochemistry and Cell Biology, 50(1), 127-131.
<a
href="http://dx.doi.org/10.1016/j.biocel.2014.02.
024">[More Information]</a>
Zheng, Z., He, X., Xie, C., Hua, S., Li, J., Wang,
T., Yao, M., Vignarajan, S., Teng, Y., Hejazi, L.,
Dong, Q., et al (2014). Targeting cytosolic
phospholipase A2 α in colorectal cancer cells
inhibits constitutively activated Protein Kinase B
(AKT) and cell proliferation. Oncotarget, 5(23),
12304-12316.
Xie, C., Powell, C., Yao, M., Wu, J., Dong, Q.
(2014). Ubiquitin-conjugating enzyme E2C: A
potential cancer biomarker. The International
Journal of Biochemistry and Cell Biology, 47,
113-117. <a
href="http://dx.doi.org/10.1016/j.biocel.2013.11.
023">[More Information]</a>
2013
Xiao, W., Graham, P., Hao, J., Chang, L., Ni, J.,
Power, C., Dong, Q., Kearsley, J., Li, Y. (2013).
Combination Therapy with the Histone
Deacetylase Inhibitor LBH589 and Radiation Is
an Effective Regimen for Prostate Cancer Cells.
PloS One, 8(8), 1-14. <a
href="http://dx.doi.org/10.1371/journal.pone.007
4253">[More Information]</a>
Hua, S., Yao, M., Vignarajan, S., Witting, P.,
Hejazi, L., Gong, Z., Teng, Y., Niknami, M.,
Assinder, S., Richardson, D., Dong, Q. (2013).
Cytosolic phospholipase A2alpha sustains
pAKT, pERK and AR levels in
PTEN-null/mutated prostate cancer cells.
Publications for Qihan Dong
Biochimica et Biophysica Acta - Molecular and
Cell Biology of Lipids, 1831 (6), 1146-1157. <a
href="http://dx.doi.org/10.1016/j.bbalip.2013.02.
011">[More Information]</a>
Dixon, K., Lui, G., Kovacevic, Z., Zhang, D.,
Yao, M., Chen, Z., Dong, Q., Assinder, S.,
Richardson, D. (2013). Dp44mT targets the
AKT, TGF-β and ERK pathways via the
metastasis suppressor NDRG1 in normal prostate
epithelial cells and prostate cancer cells. British
Journal of Cancer, 108(2), 409-419. <a
href="http://dx.doi.org/10.1038/bjc.2012.582">[
More Information]</a>
Ghalayini, M., Dong, Q., Richardson, D.,
Assinder, S. (2013). Proteolytic cleavage and
truncation of NDRG1 in human prostate cancer
cells, but not normal prostate epithelial cells.
Bioscience Reports, 33(3), 451-464. <a
href="http://dx.doi.org/10.1042/BSR20130042">
[More Information]</a>
Garbutcheon-Singh, B., Myers, S., Harper, B.,
Ng, N., Dong, Q., Xie, C., Aldrich-Wright, J.
(2013). The effects of 56MESS on mitochondrial
and cytoskeletal proteins and the cell cycle in
MDCK cells. Metallomics, 5(8), 1061-1067. <a
href="http://dx.doi.org/10.1039/c3mt00023k">[
More Information]</a>
2012
Yao, M., Xie, C., Constantine, M., Hua, S.,
Hambly, B., Jardine, G., Sved, P., Dong, Q.
(2012). How can food extracts consumed in the
Mediterranean and East Asia suppress prostate
cancer proliferation? British Journal of Nutrition,
108(3), 424-430. <a
href="http://dx.doi.org/10.1017/S000711451100
5770">[More Information]</a>
2010
Assinder, S., Au, E., Dong, Q., Winnick, C.
(2010). A novel splice variant of the
beta-tropomyosin (TPM2) gene in prostate
cancer. Molecular Carcinogenesis, 49(6),
525-531. <a
href="http://dx.doi.org/10.1002/mc.20626">[Mo
re Information]</a>
Niknami, M., Vignarajan, S., Yao, M., Hua, S.,
Witting, P., Kita, Y., Shimizu, T., Sved, P., Patel,
M., Dong, Q. (2010). Decrease in expression or
activity of cytosolic phospholipase A(2)alpha
increases cyclooxygenase-1 action: A cross-talk
between key enzymes in arachidonic acid
pathway in prostate cancer cells. Biochimica et
Biophysica Acta - Molecular and Cell Biology of
Lipids, 1801 (7), 731-737. <a
href="http://dx.doi.org/10.1016/j.bbalip.2010.03.
003">[More Information]</a>
Singh, J., Xie, C., Yao, M., Hua, S., Vignarajan,
S., Jardine, G., Hambly, B., Sved, P., Dong, Q.
(2010). Food Extracts Consumed in
Mediterranean Countries and East Asia Reduce
Protein Concentrations of Androgen Receptor,
Phospho-Protein Kinase B, and
Phospho-Cytosolic Phospholipase A2α in
Human Prostate Cancer Cells. The Journal of
Nutrition, 140(4), 786-791. <a
href="http://dx.doi.org/10.3945/jn.109.118745">
[More Information]</a>
Yao, M., Taylor, R., Richards, M., Sved, P.,
Wong, J., Eisinger, D., Xie, C., Salomon, R.,
Risbridger, G., Dong, Q. (2010).
Prostate-Regenerating Capacity of Cultured
Human Adult Prostate Epithelial Cells. Cells
Tissues Organs, 191(3), 203-212. <a
href="http://dx.doi.org/10.1159/000240244">[M
ore Information]</a>
Young, L., Dong, Q. (2010). Targeted
Amplification of Mutant Strands for Efficient
Site-Directed Mutagenesis and Mutant
Screening. In Jeff Braman (Eds.), In Vitro
Mutagenesis Protocols, (pp. 147-155). New
York: Humana Press.
2009
Niknami, M., Patel, M., Witting, P., Dong, Q.
(2009). Molecules in focus: Cytosolic
phospholipase A(2)-alpha. The International
Journal of Biochemistry and Cell Biology, 41(5),
994-997. <a
href="http://dx.doi.org/10.1016/j.biocel.2008.07.
017">[More Information]</a>
Assinder, S., Dong, Q., Mangs, A., Richardson,
D. (2009). Pharmacological targeting of the
integrated protein kinase B, phosphatase and
tensin homolog deleted on chromosome 10, and
transforming growth Factor-β pathways in
prostate cancer. Molecular Pharmacology, 75(3),
429-436. <a
href="http://dx.doi.org/10.1124/mol.108.053066
">[More Information]</a>
Niknami, M., Dong, Q., Witting, P. (2009).
Pitfalls in the use of arachidonic acid oxidation
products to assign lipoxygenase activity in
cancer cells. Free Radical Research, 43(10),
951-956. <a
href="http://dx.doi.org/10.1080/1071576090314
5013">[More Information]</a>
Salomon, R., Young, L., Macleod, D., Yu, X.,
Dong, Q. (2009). Probasin Promoter-driven
Expression of ID1 Is not Sufficient for
Carcinogenesis in Rodent Prostate. Journal of
Histochemistry and Cytochemistry: imaging the
spectrum of cell biology, 57(6), 599-604. <a
href="http://dx.doi.org/10.1369/jhc.2009.953182
">[More Information]</a>
Richards, A., McGeechan, K., Niknami, M.,
Salomon, R., Kurek, C., Dong, Q., Patel, M.
Publications for Qihan Dong
(2009). Prolonging androgen sensitivity in
prostate cancer - a role for COX inhibitors? ANZ
Journal of Surgery, 79(9), 641-647. <a
href="http://dx.doi.org/10.1111/j.1445-2197.200
9.05020.x">[More Information]</a>
Assinder, S., Dong, Q., Kovacevic, Z.,
Richardson, D. (2009). The TGF-beta, PI3K/Akt
and PTEN pathways: established and proposed
biochemical integration in prostate cancer.
Biochemical Journal, 417(2), 411-421. <a
href="http://dx.doi.org/10.1042/BJ20081610">[
More Information]</a>
2008
Niknami, M., Patel, M., Witting, P., Dong, Q.
(2008). Aberrant Activation of Arachidonic Acid
and Eicosanoid Pathways- Targets for Treating
Prostate Cancer. Recent Patents on Endocrine,
Metabolic and Immune Drug Discovery, 2(1),
9-15.
Patel, M., Singh, J., Niknami, M., Kurek, C.,
Yao, M., Lu, S., Maclean, F., King, N., Gelb, M.,
Scott, K., Dong, Q., et al (2008). Cytosolic
PhospholipaseA2-A: A Potential Therapeutic
Target for Prostate Cancer. Clinical Cancer
Research, 14(24), 8070-8079. <a
href="http://dx.doi.org/10.1158/1078-0432.CCR08-0566">[More Information]</a>
Patel, M., Kurek, C., Dong, Q. (2008). The
Arachidonic Acid Pathway and its Role in
Prostate Cancer Development and Progression.
The Journal of Urology, 179(5), 1668-1675. <a
href="http://dx.doi.org/10.1016/j.juro.2007.12.03
7">[More Information]</a>
2006
Dong, Q., Patel, M., Scott, K., Graham, G.,
Russell, P., Sved, P. (2006). Oncogenic action of
phospholipase A(2) in prostate cancer. Cancer
Letters, 240(1), 9-16. <a
href="http://dx.doi.org/10.1016/j.canlet.2005.08.
012">[More Information]</a>
Young, L., Salomon, R., Au, W., Allan, C.,
Russell, P., Dong, Q. (2006). Ornithine
decarboxylase (ODC) expression pattern in
human prostate tissues and ODC transgenic
mice. Journal of Histochemistry and
Cytochemistry: imaging the spectrum of cell
biology, 54(2), 223-229. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16234506">[More Information]</a>
Lim, W., Tan, B., Zhu, Y., Zhou, S., Armstrong,
J., Li, Q., Dong, Q., Chan, E., Smith, D., Verma,
C., et al (2006). The very C-terminus of
PRK1/PKN is essential for its activation by
RhoA and downstream signaling. Cellular
Signalling, 18(9), 1473-1481. <a
href="http://dx.doi.org/10.1016/j.cellsig.2005.11.
009">[More Information]</a>
2005
Patel, M., Tuckermann, R., Dong, Q. (2005). A
Pitfall of the
3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethon
yphenol)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay due to evaporation in wells on the
edge of a 96 well plate. Biotechnology Letters,
27(11), 805-808. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16086264">[More Information]</a>
Singh, J., Manickam, P., Shmoish, M., Natik, S.,
Denyer, G., Handelsman, D., Gong, D., Dong, Q.
(2005). Annotation of androgen dependence to
human prostate cancer-associated genes by
microarray analysis of mouse prostate. Cancer
Letters, 237(2), 298-304. <a
href="http://dx.doi.org/10.1016/j.canlet.2005.06.
008">[More Information]</a>
Dong, Q., Young, L. (2005). Development of a
murine prostatespecific 2-in-1 inducible
bicistronic expression vector. Biotechnology
Letters, 27(12), 823-8. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16086242">[More Information]</a>
Singh, J., Young, L., Handelsman, D., Dong, Q.
(2005). Molecular cloning and characterization
of a novel androgen repressible gene expressed
in the prostate epithelium. Gene, 348(1), 55-63.
<a
href="http://dx.doi.org/10.1016/j.gene.2004.12.0
47">[More Information]</a>
Dong, Q., Patel, M., Scott, K., Graham, G.,
Russell, P., Sved, P. (2005). Oncogenic action of
phospholipase A(2) in prostate cancer. Cancer
Letters, 240(1), 9-16. <a
href="http://dx.doi.org/10.1016/j.canlet.2005.08.
012">[More Information]</a>
Zhu, Y., Dong, Q., Tan, B., Lim, W., Zhou, S.,
Duan, W. (2005). The PKC alpha-D294G mutant
found in pituitary and thyroid tumors fails to
transduce extracellular signals. Cancer Research,
65(11), 4520-4524.
2004
Sved, P., Scott, K., McLeod, D., King, N., Singh,
J., Tsatralis, T., Nikolov, B., Boulas, J., Nallan,
L., Gelb, M., Dong, Q., et al (2004). Oncogenic
Action Of Secreted Phospholipase A2 In Prostate
Cancer. Cancer Research, 64(19), 6934-6940.
Young, L., Dong, Q. (2004). Two-Step Total
Gene Synthesis Method. Nucleic Acids Research,
32(7), e59.
2003
Publications for Qihan Dong
Young, L., Dong, Q. (2003). TAMS technology
for simple and efficient in vitro site-directed
mutagenesis and mutant screening. Nucleic Acids
Research, 31(3/e11), 1-3.
2002
Singh, J., Young, L., Handelsman, D., Dong, Q.
(2002). Prostate epithelial expression of a novel
androgen target gene. Journal Of Andrology,
23(5), 652-660.
2001
Chetcuti, A., Margan, S., Russell, P.,
Handelsman, D., Dong, Q., Mann, S., Rogers, J.
(2001). Identification of differentially expressed
genes in organ-confined prostate cancer by gene
expression array. The Prostate, 47, 132-140.
Chetcuti, A., Margan, S., Russell, P., Mann, S.,
Millar,, D., Clark, S., Rogers, J., Handelsman,
D., Dong, Q. (2001). Loss of annexin II heavy
and light chains in prostate cancer and its
precursors. Cancer Research, 61, 6331-6334.
Foxley, G., Dong, Q., Handelsman, D. (2001).
Quantitative reverse transcriptase polymerase
chain reaction assay for mouse androgen receptor
mRNA. Endocrine, 15, 193-198.
2000
Chua, E., Wu, W., Tran, K., McCarthy, S.,
Lauer, C., Dubourdieu, D., Packham, N.,
O'Brien, C., Turtle, J., Dong, Q. (2000).
Prevalence and Distribution of ret/ptc 1, 2, and 3
in Papillary Thyroid Carcinoma in New
Caledonia and Australia. Journal of Clinical
Endocrinology and Metabolism, 85, 2733-2739.